Integrative literature review on human papillomavirus vaccination recommendations in national immunization programs in select areas in the Asia-Pacific region
There is limited literature on current human papillomavirus (HPV) vaccination in the Asia-Pacific region. This integrative literature review was conducted to describe HPV vaccination programs in Hong Kong, Indonesia, Japan, South Korea, Malaysia, the Philippines, Singapore, Taiwan, Thailand, and Vie...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/21645515.2024.2362449 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849689250135539712 |
|---|---|
| author | Wanatpreeya Phongsamart Pei-Jen Lou Isaya Sukarom Ying-Hui Wu Omer Zaidi Frieda Du Alyssa Simon Mark Bernauer |
| author_facet | Wanatpreeya Phongsamart Pei-Jen Lou Isaya Sukarom Ying-Hui Wu Omer Zaidi Frieda Du Alyssa Simon Mark Bernauer |
| author_sort | Wanatpreeya Phongsamart |
| collection | DOAJ |
| description | There is limited literature on current human papillomavirus (HPV) vaccination in the Asia-Pacific region. This integrative literature review was conducted to describe HPV vaccination programs in Hong Kong, Indonesia, Japan, South Korea, Malaysia, the Philippines, Singapore, Taiwan, Thailand, and Vietnam. Program descriptions, recommendations, f unding, and coverage data were extracted. Twenty-five citations were included. As of 2022, eight of the 10 areas of interest include HPV in their national immunization program (NIP) for school-aged girls; full implementation in Indonesia is expected in 2023 whereas Vietnam’s NIP does not include HPV. Singapore also includes HPV vaccination for women (18–26 years). None of the HPV vaccination programs include males. In most areas (n = 7), programs include only one vaccine option. While female HPV NIPs are present in the Asia-Pacific region, opportunities remain to strengthen NIPs in broader populations (e.g., males, catch-up cohorts) to expand public health impact and provide gender equity in HPV vaccination. |
| format | Article |
| id | doaj-art-cbc714e9370d49f19a4110820bb07d97 |
| institution | DOAJ |
| issn | 2164-5515 2164-554X |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Human Vaccines & Immunotherapeutics |
| spelling | doaj-art-cbc714e9370d49f19a4110820bb07d972025-08-20T03:21:42ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2024-12-0120110.1080/21645515.2024.2362449Integrative literature review on human papillomavirus vaccination recommendations in national immunization programs in select areas in the Asia-Pacific regionWanatpreeya Phongsamart0Pei-Jen Lou1Isaya Sukarom2Ying-Hui Wu3Omer Zaidi4Frieda Du5Alyssa Simon6Mark Bernauer7Department of Pediatrics, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, ThailandDepartment of Otolaryngology, National Taiwan University Hospital and College of Medicine, Taipei City, TaiwanOutcomes Research, Regional Asia Pacific, MSD Thailand, Bangkok, ThailandGlobal Medical and Scientific Affairs, MSD Taiwan, Taipei, TaiwanHEOR & Market Access, OPEN Health, Bethesda, MD, USAHEOR & Market Access, OPEN Health, Shanghai, ChinaHEOR & Market Access, OPEN Health, Bethesda, MD, USAHEOR & Market Access, OPEN Health, Bethesda, MD, USAThere is limited literature on current human papillomavirus (HPV) vaccination in the Asia-Pacific region. This integrative literature review was conducted to describe HPV vaccination programs in Hong Kong, Indonesia, Japan, South Korea, Malaysia, the Philippines, Singapore, Taiwan, Thailand, and Vietnam. Program descriptions, recommendations, f unding, and coverage data were extracted. Twenty-five citations were included. As of 2022, eight of the 10 areas of interest include HPV in their national immunization program (NIP) for school-aged girls; full implementation in Indonesia is expected in 2023 whereas Vietnam’s NIP does not include HPV. Singapore also includes HPV vaccination for women (18–26 years). None of the HPV vaccination programs include males. In most areas (n = 7), programs include only one vaccine option. While female HPV NIPs are present in the Asia-Pacific region, opportunities remain to strengthen NIPs in broader populations (e.g., males, catch-up cohorts) to expand public health impact and provide gender equity in HPV vaccination.https://www.tandfonline.com/doi/10.1080/21645515.2024.2362449Asiahuman papillomavirusimmunizationpapillomavirus vaccinesintegrative review |
| spellingShingle | Wanatpreeya Phongsamart Pei-Jen Lou Isaya Sukarom Ying-Hui Wu Omer Zaidi Frieda Du Alyssa Simon Mark Bernauer Integrative literature review on human papillomavirus vaccination recommendations in national immunization programs in select areas in the Asia-Pacific region Human Vaccines & Immunotherapeutics Asia human papillomavirus immunization papillomavirus vaccines integrative review |
| title | Integrative literature review on human papillomavirus vaccination recommendations in national immunization programs in select areas in the Asia-Pacific region |
| title_full | Integrative literature review on human papillomavirus vaccination recommendations in national immunization programs in select areas in the Asia-Pacific region |
| title_fullStr | Integrative literature review on human papillomavirus vaccination recommendations in national immunization programs in select areas in the Asia-Pacific region |
| title_full_unstemmed | Integrative literature review on human papillomavirus vaccination recommendations in national immunization programs in select areas in the Asia-Pacific region |
| title_short | Integrative literature review on human papillomavirus vaccination recommendations in national immunization programs in select areas in the Asia-Pacific region |
| title_sort | integrative literature review on human papillomavirus vaccination recommendations in national immunization programs in select areas in the asia pacific region |
| topic | Asia human papillomavirus immunization papillomavirus vaccines integrative review |
| url | https://www.tandfonline.com/doi/10.1080/21645515.2024.2362449 |
| work_keys_str_mv | AT wanatpreeyaphongsamart integrativeliteraturereviewonhumanpapillomavirusvaccinationrecommendationsinnationalimmunizationprogramsinselectareasintheasiapacificregion AT peijenlou integrativeliteraturereviewonhumanpapillomavirusvaccinationrecommendationsinnationalimmunizationprogramsinselectareasintheasiapacificregion AT isayasukarom integrativeliteraturereviewonhumanpapillomavirusvaccinationrecommendationsinnationalimmunizationprogramsinselectareasintheasiapacificregion AT yinghuiwu integrativeliteraturereviewonhumanpapillomavirusvaccinationrecommendationsinnationalimmunizationprogramsinselectareasintheasiapacificregion AT omerzaidi integrativeliteraturereviewonhumanpapillomavirusvaccinationrecommendationsinnationalimmunizationprogramsinselectareasintheasiapacificregion AT friedadu integrativeliteraturereviewonhumanpapillomavirusvaccinationrecommendationsinnationalimmunizationprogramsinselectareasintheasiapacificregion AT alyssasimon integrativeliteraturereviewonhumanpapillomavirusvaccinationrecommendationsinnationalimmunizationprogramsinselectareasintheasiapacificregion AT markbernauer integrativeliteraturereviewonhumanpapillomavirusvaccinationrecommendationsinnationalimmunizationprogramsinselectareasintheasiapacificregion |